A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

427

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

June 21, 2024

Study Completion Date

June 21, 2024

Conditions
Atopic Dermatitis
Interventions
DRUG

AK120

subcutaneous injection once a week

DRUG

AK120

subcutaneous injection once a week

DRUG

Placebo

subcutaneous injection once a week.

DRUG

AK120

subcutaneous injection every 2 weeks.

DRUG

AK120

subcutaneous injection every 2 weeks.

DRUG

AK120

subcutaneous injection every 2 weeks.

DRUG

Placebo

subcutaneous injection every 2 weeks for 16 weeks then crossover to AK120 Regimen 4 and Regimen 5.

DRUG

AK120

subcutaneous injection every 2 weeks

DRUG

AK120

subcutaneous injection every 2 weeks.

DRUG

AK120

subcutaneous injection every 2 weeks.

Trial Locations (39)

Unknown

AkesoBio Investigative Site 2037, The First Affiliated Hospital of Bengbu Medical College, Bengbu

AkesoBio Investigative Site 2036, The First Affiliated Hospital of Wannan Medical College, Wuhu

AkesoBio Investigative Site 1001, Peking University People's Hospital, Beijing

AkesoBio Investigative Site 2044, Beijing Friendship Hospital, Capital Medical University, Beijing

AkesoBio Investigative Site 2023, Xinqiao Hospital Medical University, Chongqing

AkesoBio Investigative Site 2024, Chongqing Three Gorges Medical College, Chongqing

AkesoBio Investigative Site 2040, Chongqing Traditional Chinese Medicine Hospital, Chongqing

AkesoBio Investigative Site 2052, The First Affiliated Hospital of Chongqing Medical University, Chongqing

AkesoBio Investigative Site 2038, The First Affiliated Hospital of Fujian Medical University, Fuzhou

AkesoBio Investigative Site 2022, Dongguan People's Hospital, Dongguan

AkesoBio Investigative Site 1002, Guangdong Provincial People's Hospital, Guangzhou

AkesoBio Investigative Site 2003, Dermatology Hospital of Southern Medical University, Guangzhou

AkesoBio Investigative Site 2049, The Affiliated Hospital of Guizhou Medical University, Guiyang

AkesoBio Investigative Site 2004, The First Affiliated Hospital of Hainan Medical University, Haikou

AkesoBio Investigative Site 2001, Affiliated Hospital of Chengde medical university, Chengde

AkesoBio Investigative Site 2010, Nanyang First People's Hospital National Third Class A Hospital, Nanyang

AkesoBio Investigative Site 2051, Jingzhou Central Hospital, Jingzhou

AkesoBio Investigative Site 1005, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

AkesoBio Investigative Site 2046, The Third Xiangya Hospital of Central South University, Changsha

AkesoBio Investigative Site 2008, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

AkesoBio Investigative Site 2048, The First People's Hospital of Changzhou, Changzhou

AkesoBio Investigative Site 2050, Wuxi Second People's Hospital, Wuxi

AkesoBio Investigative Site 2025, Affiliated Hospital of Jiangsu University, Zhenjiang

AkesoBio Investigative Site 2032, The First Affiliated Hospital of Gannan Medical College, Ganzhou

AkesoBio Investigative Site 2011, Northeast International Hospital, Shenyang

AkesoBio Investigative Site 2039, Shandong Provincial Dermatology Hospital, Jinan

AkesoBio Investigative Site 2041, Qilu Hospital of Shandong University, Jinan

AkesoBio Investigative Site 1003, Shanghai Skin Disease Hospital, Shanghai

AkesoBio Investigative Site 2027, Medical School of Yanan University, Xianyang

AkesoBio Investigative Site 2029, West China Hospital,Sichuan University, Chengdu

AkesoBio Investigative Site 2034, Chengdu Second People's Hospital, Chengdu

AkesoBio Investigative Site 2013, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin

AkesoBio Investigative Site 2019, Tianjin Medical University General Hospital, Tianjin

AkesoBio Investigative Site 2043, First Affiliated Hospital of Kunming Medical University, Kunming

AkesoBio Investigative Site 1004, Zhejiang Provincial People's Hospital, Hangzhou

AkesoBio Investigative Site 2006,Affiliated Hangzhou First People's Hospital, Hangzhou

AkesoBio Investigative Site 2007, Hangzhou Third People's Hospital, Hangzhou

AkesoBio Investigative Site 2035, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

AkesoBio Investigative Site 2009, The First Hospital of Jiaxing, Jiaxing

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Akeso

INDUSTRY